Impact de la dose d’afatinib sur la tolérance et l’efficacité en vie réelle chez des patients avec CBNPC avancé EGFR muté
Year: 2018
Type: article
Study design: Observational Study
Source: Revue des Maladies Respiratoires
Authors: B. Halmos, E.H. Tan, R. Soo, J. Cadranel, M. Ki Lee, P. Foucher, T.C. Hsia, M. Hochmair, F. Griesinger, T. Hida, E. Kim, B. Melosky, A. Märten, E. Carcereny
Institutions: Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, National Cancer Centre Singapore, National University Hospital, Sorbonne Université, Hôpital Tenon, Pusan National University Hospital, CHU Dijon Bourgogne, China Medical University, China Medical University Hospital, Otto Wagner Hospital, Carl von Ossietzky Universität Oldenburg, Pius Hospital Oldenburg, Aichi Cancer Center, Carolinas Healthcare System, Levine Cancer Institute, University of British Columbia, Boehringer Ingelheim (Germany), Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol
Language: French
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2907133870